(NTNX) Nutanix - Ratings and Ratios
Hyperconverged, Hybrid Multicloud, Kubernetes, Storage, Database
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 67.4% |
| Value at Risk 5%th | 100% |
| Relative Tail Risk | -9.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.74 |
| Alpha | -52.57 |
| CAGR/Max DD | 0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.593 |
| Beta | 1.213 |
| Beta Downside | 1.387 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.46% |
| Mean DD | 12.11% |
| Median DD | 11.10% |
Description: NTNX Nutanix October 16, 2025
Nutanix Inc. (NASDAQ:NTNX) delivers an enterprise-cloud platform that spans North America, Europe, APAC, the Middle East, Latin America and Africa. Its portfolio includes hyper-converged infrastructure (HCI) software, the Nutanix Cloud Platform for hybrid-multicloud deployments, integrated Kubernetes services, software-defined networking, unified management (Prism, Cloud Manager, Central) and a suite of data-storage options (file, block, object) plus AI-focused services such as Enterprise AI and GPT-in-a-Box. The company also offers professional services and targets a broad set of verticals-including financial services, manufacturing, healthcare and telecom.
Key recent metrics: Nutanix reported FY 2024 revenue of $1.03 billion, a 6 % year-over-year increase, with subscription ARR now exceeding $2.5 billion-indicating a shift toward higher-margin SaaS contracts. The hyper-converged market is projected to grow at a ~12 % CAGR through 2027, driven by enterprises consolidating data-center footprints and adopting AI/ML workloads, which Nutanix positions as a core growth engine.
For a deeper, data-driven assessment of Nutanix’s valuation and risk profile, you may find the analyst tools on ValueRay useful for extending this initial overview.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (220.5m TTM) > 0 and > 6% of Revenue (6% = 157.1m TTM) |
| FCFTA 0.23 (>2.0%) and ΔFCFTA -5.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.34% (prev 6.81%; Δ 40.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.26 (>3.0%) and CFO 856.5m > Net Income 220.5m (YES >=105%, WARN >=100%) |
| Net Debt (700.1m) to EBITDA (306.7m) ratio: 2.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (296.5m) change vs 12m ago 2.66% (target <= -2.0% for YES) |
| Gross Margin 87.03% (prev 85.42%; Δ 1.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 95.09% (prev 102.2%; Δ -7.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 12.32 (EBITDA TTM 306.7m / Interest Expense TTM 19.0m) >= 6 (WARN >= 3) |
Altman Z'' -3.04
| (A) 0.37 = (Total Current Assets 2.64b - Total Current Liabilities 1.40b) / Total Assets 3.32b |
| (B) -1.47 = Retained Earnings (Balance) -4.87b / Total Assets 3.32b |
| warn (B) unusual magnitude: -1.47 — check mapping/units |
| (C) 0.08 = EBIT TTM 233.8m / Avg Total Assets 2.75b |
| (D) -1.22 = Book Value of Equity -4.87b / Total Liabilities 3.99b |
| Total Rating: -3.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.08
| 1. Piotroski 6.0pt |
| 2. FCF Yield 6.18% |
| 3. FCF Margin 29.52% |
| 4. Debt/Equity -2.21 |
| 5. Debt/Ebitda 2.28 |
| 6. ROIC - WACC (= 27.09)% |
| 7. RoE -30.61% |
| 8. Rev. Trend 96.86% |
| 9. EPS Trend 88.02% |
What is the price of NTNX shares?
Over the past week, the price has changed by -18.04%, over one month by -32.90%, over three months by -28.78% and over the past year by -27.74%.
Is NTNX a buy, sell or hold?
- Strong Buy: 8
- Buy: 7
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NTNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.7 | 47.9% |
| Analysts Target Price | 70.7 | 47.9% |
| ValueRay Target Price | 47 | -1.6% |
NTNX Fundamental Data Overview November 29, 2025
P/E Trailing = 63.6053
P/E Forward = 25.641
P/S = 5.0008
P/EG = 1.2212
Beta = 0.497
Revenue TTM = 2.62b USD
EBIT TTM = 233.8m USD
EBITDA TTM = 306.7m USD
Long Term Debt = 1.34b USD (from longTermDebt, last fiscal year)
Short Term Debt = 24.1m USD (from shortTermDebt, last quarter)
Debt = 1.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 700.1m USD (from netDebt column, last quarter)
Enterprise Value = 12.51b USD (13.09b + Debt 1.48b - CCE 2.06b)
Interest Coverage Ratio = 12.32 (Ebit TTM 233.8m / Interest Expense TTM 19.0m)
FCF Yield = 6.18% (FCF TTM 772.8m / Enterprise Value 12.51b)
FCF Margin = 29.52% (FCF TTM 772.8m / Revenue TTM 2.62b)
Net Margin = 8.43% (Net Income TTM 220.5m / Revenue TTM 2.62b)
Gross Margin = 87.03% ((Revenue TTM 2.62b - Cost of Revenue TTM 339.6m) / Revenue TTM)
Gross Margin QoQ = 86.96% (prev 87.17%)
Tobins Q-Ratio = 3.76 (Enterprise Value 12.51b / Total Assets 3.32b)
Interest Expense / Debt = 0.97% (Interest Expense 14.4m / Debt 1.48b)
Taxrate = 5.30% (3.48m / 65.6m)
NOPAT = 221.4m (EBIT 233.8m * (1 - 5.30%))
Current Ratio = 1.89 (Total Current Assets 2.64b / Total Current Liabilities 1.40b)
Debt / Equity = -2.21 (negative equity) (Debt 1.48b / totalStockholderEquity, last quarter -668.6m)
Debt / EBITDA = 2.28 (Net Debt 700.1m / EBITDA 306.7m)
Debt / FCF = 0.91 (Net Debt 700.1m / FCF TTM 772.8m)
Total Stockholder Equity = -720.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.63% (Net Income 220.5m / Total Assets 3.32b)
RoE = -30.61% (negative equity) (Net Income TTM 220.5m / Total Stockholder Equity -720.6m)
RoCE = 37.51% (EBIT 233.8m / Capital Employed (Equity -720.6m + L.T.Debt 1.34b))
RoIC = 36.61% (NOPAT 221.4m / Invested Capital 604.7m)
WACC = 9.52% (E(13.09b)/V(14.57b) * Re(10.49%) + D(1.48b)/V(14.57b) * Rd(0.97%) * (1-Tc(0.05)))
Discount Rate = 10.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.81%
[DCF Debug] Terminal Value 73.90% ; FCFE base≈710.5m ; Y1≈876.5m ; Y5≈1.50b
Fair Price DCF = 62.41 (DCF Value 16.90b / Shares Outstanding 270.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 88.02 | EPS CAGR: 41.00% | SUE: 0.0 | # QB: 0
Revenue Correlation: 96.86 | Revenue CAGR: 13.79% | SUE: -1.86 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.44 | Chg30d=-0.113 | Revisions Net=-2 | Analysts=15
EPS current Year (2026-07-31): EPS=1.80 | Chg30d=-0.088 | Revisions Net=+0 | Growth EPS=+10.9% | Growth Revenue=+12.5%
EPS next Year (2027-07-31): EPS=2.18 | Chg30d=-0.086 | Revisions Net=-2 | Growth EPS=+21.1% | Growth Revenue=+14.2%
Additional Sources for NTNX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle